Determination of bioavailability of digi
β
R. G. Stoll; M. S. Christensen; E. Sakmar; D. Blair; J. G. Wagner
π
Article
π
1973
π
John Wiley and Sons
π
English
β 613 KB
A commercial digitoxin radioimmunoassay procedure, normally used to evaluate equilibrium-state plasma levels, was modified such that the sensitivity was increased 20-fold. Due to the extensive metabolism of digitoxin in man, the specificity of the assay procedure for digitoxin was determined against